394420.KQ RecensMedical, Inc.
- Market cap
- KRW 56.6B
- P/E
- -
- P/B
- 2.85x
- ROE
- -47.1%
- Dividend yield
- -
- Fundamental score
- 1.3/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 394420.KQ undervalued?
Graham numberThe Graham number of RecensMedical, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RecensMedical, Inc. fundamental analysis
5 of 21 checks passedROE 0/2
Low return on equity (-47.1%), below 10%.
ROA 0/1
Return on assets (-31.4%) is below the industry median (-9.3%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-143.8%) is below the industry median (-3.8%).
Revenue Growth 2/2
Revenue grew 215.3% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (9.5%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash covers 0.2 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (2.9x) is below the industry median (3.5x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
RecensMedical, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RecensMedical, Inc.
RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company's products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise,…
Full company profileRecensMedical, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RecensMedical, Inc. annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 282M | 5.77B | 6.26B | 8.83B | 5.42B |
| Gross Profit | 113M | 3.04B | 1.37B | 4.33B | 2.89B |
| Operating Income | -20.2B | -12.6B | -14.2B | -10.6B | -10.3B |
| EBITDA | -38.4B | -3.98B | -3.56B | -16.2B | -8.35B |
| Net Income | -41.0B | -7.57B | -7.84B | -19.1B | -9.34B |
| EPS | -3,778 | -698 | -723 | -1,762 | -861 |
| Balance Sheet | |||||
| Total Assets | 25.6B | 15.2B | 20.1B | 12.0B | 29.8B |
| Total Liabilities | 104B | 99.2B | 111B | 5.03B | 9.91B |
| Shareholders' Equity | -78.3B | -84.0B | -90.6B | 6.98B | 19.9B |
| Cash & Short-term Investments | 9.40B | 2.57B | 5.30B | 988M | 3.67B |
| Cash Flow | |||||
| Operating Cash Flow | -22.0B | -13.3B | -9.73B | -8.59B | -14.0B |
| Capital Expenditure | 902M | 253M | 487M | 807M | 1.47B |
| Free Cash Flow | -22.9B | -13.5B | -10.2B | -9.40B | -15.5B |
| Ratios | |||||
| ROE | - | - | - | -274.0% | -47.1% |
| ROA | -159.9% | -49.7% | -39.0% | -159.2% | -31.4% |
| Net Profit Margin | -14,549.3% | -131.2% | -125.3% | -216.6% | -172.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
RecensMedical, Inc. dividends
RecensMedical, Inc. has not paid dividends in the last 4 fiscal years.
Who owns RecensMedical, Inc.
- Insiders 30.51%
- Institutions 13.91%
- Public & others 55.58%
- Shares outstanding 11.0M
- Free float 6.39M
RecensMedical, Inc. company profile
- Company name
- RecensMedical, Inc.
- Ticker
- 394420.KQ
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 50
- Fiscal year end
- December
- Address
- Dongtan SK V1 Center, Hwaseong-si, South Korea, 18468
- Phone
- 82 31 8043 3036
- Website
- recensmedical.co.kr
About RecensMedical, Inc.
RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company's products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction of pain, swelling, inflammation, and hematoma from minor surgical procedures, minor sprains or other minor sports injuries. Additionally, it offers TargetCool+, a spray syringe; and VetEase, a spray syringe for animals. Its portfolio of clinical program includes ocular anesthesia, actinic keratosis, eczema, rosacea, prurigo nodularis, and atopic dermatitis. The company was founded in 2016 and is based in Hwaseong-si, South Korea.
RecensMedical, Inc. management
5- Mr. Gun-ho KimCo-CEO, CTO & Inside Director · born 1980
- Ms. Uikyung ChoiCo-CEO & Inside Director · born 1971
- Mr. SeWang KimMD, CFO & Inside Director · born 1981
- Mr. Yongjin LeeMD & Marketing Director · born 1981
- Mr. Yujin ChoMD & Production Headquarters Manager · born 1971